Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
0.800
+0.029 (3.71%)
Feb 21, 2025, 4:00 PM EST - Market closed
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $11.30 million as of February 21, 2025. Its market cap has decreased by -23.14% in one year.
Market Cap
11.30M
Enterprise Value
4.03M
1-Year Change
-23.14%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since August 4, 2015, Indaptus Therapeutics's market cap has decreased from $60.70M to $11.30M, a decrease of -81.39%. That is a compound annual growth rate of -16.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 8.20M | -4.65% |
| Dec 31, 2024 | 8.60M | -41.89% |
| Dec 29, 2023 | 14.80M | 23.33% |
| Dec 30, 2022 | 12.00M | -74.30% |
| Dec 31, 2021 | 46.70M | 243.38% |
| Dec 31, 2020 | 13.60M | -22.29% |
| Dec 31, 2019 | 17.50M | -91.10% |
| Dec 31, 2018 | 196.60M | 233.22% |
| Dec 29, 2017 | 59.00M | -9.65% |
| Dec 30, 2016 | 65.30M | 20.48% |
| Dec 31, 2015 | 54.20M | -10.71% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |